Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC Post-intensive Care Trial
NCT04591574Active, not recruiting
- Sponsor
- University of Edinburgh
- Start
- Sep 2020
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of red blood cells in anaemia, sponsored by University of Edinburgh. Primary endpoint: Physical Component Score of the SF-36 Health Related Quality of Life at 3 months. Started Sep 2020; status: active, not recruiting.
02
Drugs
red blood cells
03
Conditions
anaemia
Beyond the preview
Go deeper on NCT04591574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04591574.